UNLABELLED: We propose (18)F-FDG PET as a method to monitor acute rejection of allogeneic renal transplants in a rat model. METHODS: Allogeneically transplanted (aTX) rats (binephrectomized Lewis-brown Norway to Lewis) served as the renal transplant model. aTX rats treated with cyclosporine A (CSA) served as a therapy monitoring group. Healthy control rats, rats with acute CSA nephrotoxicity, rats with acute tubular necrosis, syngeneically transplanted (sTX) rats, and aTX rats treated with CSA since postoperative day 0 served as controls. After surgery, renal glucose metabolism was assessed in vivo serially up to postoperative day 7 by performing small-animal PET 3 h after intravenous injection of 30 MBq of (18)F-FDG. Mean radioactivity (cps/mm(3) of tissue) was measured and the percentage injected dose calculated. Results were confirmed by histologic, functional, and autoradiographic analysis. RESULTS: Renal (18)F-FDG uptake was significantly elevated at postoperative day 4 in aTX rats, when compared with control, sTX, acute tubular necrosis, or CSA-treated rats (P < 0.05). In vivo (18)F-FDG uptake correlated with the results of autoradiography and with inflammatory infiltrates observed on histologic examination. Notably, (18)F-FDG PET assessed the response to therapy 48 h earlier than the time at which serum creatinine decreased and when histologic examination still showed signs of allograft rejection. In aTX rats, the CSA-susceptible graft infiltrate was dominated by activated cytotoxic T cells and monocytes/macrophages. CONCLUSION: (18)F-FDG PET is an option to noninvasively assess early response to therapy in rat renal allograft rejection.
UNLABELLED: We propose (18)F-FDG PET as a method to monitor acute rejection of allogeneic renal transplants in a rat model. METHODS: Allogeneically transplanted (aTX) rats (binephrectomized Lewis-brown Norway to Lewis) served as the renal transplant model. aTXrats treated with cyclosporine A (CSA) served as a therapy monitoring group. Healthy control rats, rats with acute CSAnephrotoxicity, rats with acute tubular necrosis, syngeneically transplanted (sTX) rats, and aTXrats treated with CSA since postoperative day 0 served as controls. After surgery, renal glucose metabolism was assessed in vivo serially up to postoperative day 7 by performing small-animal PET 3 h after intravenous injection of 30 MBq of (18)F-FDG. Mean radioactivity (cps/mm(3) of tissue) was measured and the percentage injected dose calculated. Results were confirmed by histologic, functional, and autoradiographic analysis. RESULTS: Renal (18)F-FDG uptake was significantly elevated at postoperative day 4 in aTXrats, when compared with control, sTX, acute tubular necrosis, or CSA-treated rats (P < 0.05). In vivo (18)F-FDG uptake correlated with the results of autoradiography and with inflammatory infiltrates observed on histologic examination. Notably, (18)F-FDG PET assessed the response to therapy 48 h earlier than the time at which serum creatinine decreased and when histologic examination still showed signs of allograft rejection. In aTXrats, the CSA-susceptible graft infiltrate was dominated by activated cytotoxic T cells and monocytes/macrophages. CONCLUSION: (18)F-FDG PET is an option to noninvasively assess early response to therapy in rat renal allograft rejection.
Authors: Michael P Lisanti; Ubaldo E Martinez-Outschoorn; Zhao Lin; Stephanos Pavlides; Diana Whitaker-Menezes; Richard G Pestell; Anthony Howell; Federica Sotgia Journal: Cell Cycle Date: 2011-08-01 Impact factor: 4.534
Authors: Stan Benjamens; Andor W J M Glaudemans; Stefan P Berger; Riemer H J A Slart; Robert A Pol Journal: Eur Radiol Date: 2018-03-07 Impact factor: 5.315
Authors: D L Chen; X Wang; S Yamamoto; D Carpenter; J T Engle; W Li; X Lin; D Kreisel; A S Krupnick; H J Huang; A E Gelman Journal: Am J Transplant Date: 2013-08-08 Impact factor: 8.086
Authors: Alexander Grabner; Dominik Kentrup; Uta Schnöckel; Gert Gabriëls; Rita Schröter; Hermann Pavenstädt; Otmar Schober; Eberhard Schlatter; Michael Schäfers; Stefan Reuter Journal: J Vis Exp Date: 2013-04-28 Impact factor: 1.355
Authors: Dominik Kentrup; Stefan Reuter; Uta Schnöckel; Alexander Grabner; Bayram Edemir; Hermann Pavenstädt; Otmar Schober; Michael Schäfers; Eberhard Schlatter; Eckhart Büssemaker Journal: PLoS One Date: 2011-10-21 Impact factor: 3.240
Authors: Helga Pawelski; Uta Schnöckel; Dominik Kentrup; Alexander Grabner; Michael Schäfers; Stefan Reuter Journal: Biomed Res Int Date: 2014-04-01 Impact factor: 3.411